Published in Cell Signal on March 12, 2014
miRNA-based therapies: strategies and delivery platforms for oligonucleotide and non-oligonucleotide agents. Future Med Chem (2014) 0.84
Downregulation of rho-associated protein kinase 1 by miR-124 in colorectal cancer. World J Gastroenterol (2015) 0.80
The Three Paralogous MicroRNA Clusters in Development and Disease, miR-17-92, miR-106a-363, and miR-106b-25. Scientifica (Cairo) (2016) 0.80
MicroRNA-363 targets myosin 1B to reduce cellular migration in head and neck cancer. BMC Cancer (2015) 0.79
MicroRNA-363-3p inhibits papillary thyroid carcinoma progression by targeting PIK3CA. Am J Cancer Res (2017) 0.78
REG4 is a transcriptional target of GATA6 and is essential for colorectal tumorigenesis. Sci Rep (2015) 0.76
microRNA-363 plays a tumor suppressive role in osteosarcoma by directly targeting MAP2K4. Int J Clin Exp Med (2015) 0.75
miR-363-3p inhibits tumor growth by targeting PCNA in lung adenocarcinoma. Oncotarget (2017) 0.75
Onco-GPCR signaling and dysregulated expression of microRNAs in human cancer. J Hum Genet (2016) 0.75
Role of microRNAs in inflammation-associated liver cancer. Cancer Biol Med (2016) 0.75
Targeting the MIR34C-5p-ATG4B-autophagy axis enhances the sensitivity of cervical cancer cells to pirarubicin. Autophagy (2016) 0.75
Role of Sphingosine-1-Phosphate in Mast Cell Functions and Asthma and Its Regulation by Non-Coding RNA. Front Immunol (2017) 0.75
Modulation of Host miRNAs Transcriptome in Lung and Spleen of Peste des Petits Ruminants Virus Infected Sheep and Goats. Front Microbiol (2017) 0.75
Downregulation of human farnesoid X receptor by miR-421 promotes proliferation and migration of hepatocellular carcinoma cells. Mol Cancer Res (2012) 1.07
MicroRNA-1 and microRNA-206 suppress LXRα-induced lipogenesis in hepatocytes. Cell Signal (2013) 0.96
FXR ligands protect against hepatocellular inflammation via SOCS3 induction. Cell Signal (2012) 0.92
MicroRNA-613 represses lipogenesis in HepG2 cells by downregulating LXRα. Lipids Health Dis (2013) 0.90
The FOXM1-induced resistance to oxaliplatin is partially mediated by its novel target gene Mcl-1 in gastric cancer cells. Biochim Biophys Acta (2014) 0.85
HCC cells with high levels of Bcl-2 are resistant to ABT-737 via activation of the ROS-JNK-autophagy pathway. Free Radic Biol Med (2014) 0.85
FXR induces SOCS3 and suppresses hepatocellular carcinoma. Oncotarget (2015) 0.79
The mutual regulation between miR-214 and A2AR signaling plays an important role in inflammatory response. Cell Signal (2015) 0.77
Activation of LXR attenuates collagen-induced arthritis via suppressing BLyS production. Clin Immunol (2015) 0.77
SARI, a novel target gene of glucocorticoid receptor, plays an important role in dexamethasone-mediated killing of B lymphoma cells. Cancer Lett (2016) 0.75
Dichloroacetate and metformin synergistically suppress the growth of ovarian cancer cells. Oncotarget (2016) 0.75
Activation of FXR protects against renal fibrosis via suppressing Smad3 expression. Sci Rep (2016) 0.75
Inhibition of COX2 enhances the chemosensitivity of dichloroacetate in cervical cancer cells. Oncotarget (2017) 0.75
HSF1 upregulates ATG4B expression and enhances epirubicin-induced protective autophagy in hepatocellular carcinoma cells. Cancer Lett (2017) 0.75
Inhibition of COX2 enhances the chemosensitivity of dichloroacetate in cervical cancer cells. Oncotarget (2017) 0.75
lncRNA HULC promotes the growth of hepatocellular carcinoma cells via stabilizing COX-2 protein. Biochem Biophys Res Commun (2017) 0.75
Induction of SOCS3 by liver X receptor suppresses the proliferation of hepatocellular carcinoma cells. Oncotarget (2017) 0.75